Shares of Aradigm Corporation (NASDAQ:ARDM) gapped up prior to trading on Monday . The stock had previously closed at $3.02, but opened at $2.53. Aradigm Corporation shares last traded at $2.99, with a volume of 4,194,960 shares traded.

Separately, Zacks Investment Research upgraded Aradigm Corporation from a “hold” rating to a “buy” rating and set a $1.50 target price for the company in a research report on Tuesday, September 5th.

Aradigm Corporation (NASDAQ:ARDM) last released its quarterly earnings results on Thursday, August 10th. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of ($0.30) by $0.37. The business had revenue of $7.68 million during the quarter. Aradigm Corporation had a negative return on equity of 665.03% and a negative net margin of 196.65%.

ILLEGAL ACTIVITY NOTICE: “Aradigm Corporation (ARDM) Shares Gap Up to $2.53” was posted by Daily Political and is owned by of Daily Political. If you are viewing this article on another domain, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark law. The correct version of this article can be accessed at https://www.dailypolitical.com/2017/09/25/aradigm-corporation-ardm-shares-gap-up-to-2-53.html.

Aradigm Corporation Company Profile

Aradigm Corporation is a pharmaceutical company focused on the development and commercialization of products for the treatment and prevention of severe respiratory diseases. The Company’s lead product candidate is Pulmaquin inhaled ciprofloxacin, which is in Phase III clinical trials. It offers AERx pulmonary drug delivery platform and other technologies.

Receive News & Ratings for Aradigm Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aradigm Corporation and related companies with MarketBeat.com's FREE daily email newsletter.